These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 10873088

  • 1. The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study.
    Streckfus C, Bigler L, Dellinger T, Dai X, Kingman A, Thigpen JT.
    Clin Cancer Res; 2000 Jun; 6(6):2363-70. PubMed ID: 10873088
    [Abstract] [Full Text] [Related]

  • 2. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.
    Chen CH, Lin YS, Lin CC, Yang YH, Ho YP, Tsai CC.
    J Oral Pathol Med; 2004 Nov; 33(10):589-94. PubMed ID: 15482324
    [Abstract] [Full Text] [Related]

  • 3. Serum c-erbB-2 protein in breast cancer patients.
    Chearskul S, Sinlarat P, Bhothisuwan K, Churintrapun M, Ornrhebroi S, Klinsala N, Sungkabunchoo S.
    J Med Assoc Thai; 2000 Aug; 83(8):886-93. PubMed ID: 10998842
    [Abstract] [Full Text] [Related]

  • 4. Prospective evaluation of tumor markers (c-erbB-2 oncoprotein, CEA and CA 15.3) in patients with locoregional breast cancer.
    Molina R, Filella X, Zanon G, Pahisa J, Alicarte J, Munoz M, Farrus B, Ballesta AM.
    Anticancer Res; 2003 Aug; 23(2A):1043-50. PubMed ID: 12820345
    [Abstract] [Full Text] [Related]

  • 5. Tissue and serum c-erbB-2 and tissue EGFR in breast carcinoma: three years follow-up.
    Mansour OA, Zekri AR, Harvey J, Teramoto Y, el-Ahmady O.
    Anticancer Res; 1997 Aug; 17(4B):3101-6. PubMed ID: 9329611
    [Abstract] [Full Text] [Related]

  • 6. ELISA for quantitation of serum C-erbB-2 oncoprotein in breast cancer patients.
    Meenakshi A, Kumar RS, Kumar NS.
    J Immunoassay Immunochem; 2002 Aug; 23(3):293-305. PubMed ID: 12227416
    [Abstract] [Full Text] [Related]

  • 7. Circulating HER2 extracellular domain and resistance to chemotherapy in advanced breast cancer.
    Colomer R, Montero S, Lluch A, Ojeda B, Barnadas A, Casado A, Massutí B, Cortés-Funes H, Lloveras B.
    Clin Cancer Res; 2000 Jun; 6(6):2356-62. PubMed ID: 10873087
    [Abstract] [Full Text] [Related]

  • 8. The expression of the c-erbB-2 receptor protein in glandular salivary secretions.
    Streckfus CF, Bigler L, Dellinger T, Kuhn M, Chouinard N, Dai X.
    J Oral Pathol Med; 2004 Nov; 33(10):595-600. PubMed ID: 15482325
    [Abstract] [Full Text] [Related]

  • 9. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.
    Ławicki S, Szmitkowski M, Wojtukiewicz M.
    Clin Chim Acta; 2006 Sep; 371(1-2):112-6. PubMed ID: 16631152
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer.
    Eskelinen M, Kataja V, Hämäläinen E, Kosma VM, Penttilä I, Alhava E.
    Anticancer Res; 1997 Sep; 17(2B):1231-4. PubMed ID: 9137478
    [Abstract] [Full Text] [Related]

  • 13. Sustained delivery of Her-2/neu antibody by TCPL delivery device using adult male rats as a model.
    Brinkley J, Copeland L, Streckfus C, Tucci M, Benghuzzi H.
    Biomed Sci Instrum; 2003 Sep; 39():324-8. PubMed ID: 12724914
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancer.
    Bramwell VH, Doig GS, Tuck AB, Wilson SM, Tonkin KS, Tomiak A, Perera F, Vandenberg TA, Chambers AF.
    Breast Cancer Res Treat; 2009 Apr; 114(3):503-11. PubMed ID: 18437556
    [Abstract] [Full Text] [Related]

  • 16. erbB-2 and myc oncoproteins in sera and tumors of breast cancer patients.
    Breuer B, De Vivo I, Luo JC, Smith S, Pincus MR, Tatum AH, Daucher J, Minick CR, Miller DG, Nowak EJ.
    Cancer Epidemiol Biomarkers Prev; 1994 Apr; 3(1):63-6. PubMed ID: 7906981
    [Abstract] [Full Text] [Related]

  • 17. Relation between hemostatic parameters and prognostic/predictive factors in breast cancer.
    Yigit E, Gönüllü G, Yücel I, Turgut M, Erdem D, Cakar B.
    Eur J Intern Med; 2008 Dec; 19(8):602-7. PubMed ID: 19046726
    [Abstract] [Full Text] [Related]

  • 18. Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma.
    Sorak M, Arsenijević S, Lukić G, Arsenijević N, Ristić P, Pavlović S, Popović S, Baskić D.
    J BUON; 2007 Dec; 12(1):99-104. PubMed ID: 17436409
    [Abstract] [Full Text] [Related]

  • 19. Angiogenesis and c-erbB-2 (HER2/neu) overexpression status in primary breast cancer patients: an analysis of 158 needle core biopsies.
    Vameşu S.
    Rom J Morphol Embryol; 2007 Dec; 48(2):121-9. PubMed ID: 17641798
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.